Reoperation combining re-cytoreductive surgery and re-HIPEC for recurrent peritoneal carcinomatosis

Journal of B.U.ON.

Volumn 17, Issue 3, 2012, Pages 522-525

  Spiliotis, John ^a   Vaxevanidou, A ^b   Halkia, E ^a   Hadjigeorgiou, G ^a   Datsis, A ^c  

^a METAXA CANCER HOSPITAL   (Greece)

^b Gennimatas General Hospital   (Greece)

^c Department of Surgery   (Greece)

Author keywords

Cytoreductive surgery; HIPEC; Peritoneal carcinomatosis

Indexed keywords

GLUCOSE; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LAPAROTOMY; LIVER METASTASIS; LUNG METASTASIS; MALE; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PANCREAS FISTULA; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RECURRENT CANCER; REOPERATION; RESPIRATORY DISTRESS; SURGICAL MORTALITY; UTERUS SARCOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; REOPERATION; SURVIVAL RATE;

EID: 84867559709     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cao C, Yan T, Black D et al. A systemic review and metaanalysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009; 16: 2152-2165.
2. Spiliotis J, Halkia E, Efstathiou E. Peritoneal carcinomatosis 2011. It's about time for chemosurgery. J BUON 2011; 16: 400-408.
3. Mahteme H, Hansson J, Berglung A et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004; 90: 403-407. (Pubitemid 38250636)
4. Jayne DG, Fook S, Loi C et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550. (Pubitemid 35404323)
5. Spiliotis J. Peritoneal carcinomatosis, cytoreductive surgery and HIPEC: a ray of hope for cure. Hepatogastroenterology 2010; 102-103: 1173-1177.
6. Levine E. The randomized trial of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion: What does and does not tell us. Ann Surg Oncol 2008; 15: 2633-2635.
7. Kianmanesh R, Scaringi S, Sabate JM et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastasis. Ann Surg Oncol 2007; 245: 597-603. (Pubitemid 46555664)
8. Verwaal VJ, Bott H, Aleman B et al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and HIPEC: location, treatment and outcome. Ann Surg Oncol 2004; 11: 375-379. (Pubitemid 40486746)
9. Bijelic L, Yan TD, Sugarbaker PH. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 2008; 98: 295-299.
10. Spiliotis J, Tentes AA, Vaxevanidou A et al. Cytoreductive surgery and HIPEC in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece. J BUON 2008; 13: 205-210. (Pubitemid 351836702)
11. Spiliotis J, Vaxevanidou A, Datsis A et al. Peritoneal carcinomatosis: intraoperative and postoperative assessment of patients undergoing cytoreduction and HIPEC. Hepatogastroenterology 2010; 102-103: 1052-1059.
12. Sugarbaker PH. Management of peritoneal surface malignancy; a short history. Recent Results Cancer Res 2007; 169: 1-9.
13. Sugarbaker PH. Are there curative options to peritoneal carcinomatosis? Ann Surg 2005; 242: 748-750.
14. Spiliotis J, Rog-dakis A, Vaxevanidou A et al. Morbidity and mortality of cytoreductive surgery and HIPEC in the management of peritoneal carcinomatosis. J. BUON 2009; 14: 259-264.
15. Yan TD, Welch L, Black D et al. A systemic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Oncol 2007; 18: 827-834. (Pubitemid 47054078)
16. Sugarbaker PH. New standards of care for appendiceal epithelial neoplasms and PMP syndrome. Lancet Oncol 2006; 7: 69-76. (Pubitemid 43025395)
17. Tominaga T, Sakabe T, Koyame Y et al. Prognostic factors for patients with colon and rectal carcinoma treated with resections only: five-year follow-up report. Cancer 1996; 78: 403-408. (Pubitemid 26250523)
18. Brouquet A, Goere D, Lefevre J et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome. Ann Surg Oncol 2009; 16: 2744-2751.